Summary
Further key aspects of the report:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global PDE Inhibitors market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global PDE Inhibitors market segmented into
PDE5
PDE4
Viagra
Cialis
Levitra
Others
Based on the end-use, the global PDE Inhibitors market classified into
Genitourinary
Cardiovascular Diseases
Neurological Diseases
Dermatological Disorders
Respiratory Diseases
Other Indications
Based on geography, the global PDE Inhibitors market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Hanmi Science Holding
Boehringer Ingelheim
Takeda Pharmaceuticals
Pfizer
Omeros
Anacor Pharmaceuticals
Otsuka
Chiesi Farmaceutici
Verona Pharma
NuSirt Biopharma
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL PDE INHIBITORS INDUSTRY
2.1 Summary about PDE Inhibitors Industry
2.2 PDE Inhibitors Market Trends
2.2.1 PDE Inhibitors Production & Consumption Trends
2.2.2 PDE Inhibitors Demand Structure Trends
2.3 PDE Inhibitors Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 PDE5
4.2.2 PDE4
4.2.3 Viagra
4.2.4 Cialis
4.2.5 Levitra
4.2.6 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Genitourinary
4.3.2 Cardiovascular Diseases
4.3.3 Neurological Diseases
4.3.4 Dermatological Disorders
4.3.5 Respiratory Diseases
4.3.6 Other Indications
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 PDE5
5.2.2 PDE4
5.2.3 Viagra
5.2.4 Cialis
5.2.5 Levitra
5.2.6 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Genitourinary
5.3.2 Cardiovascular Diseases
5.3.3 Neurological Diseases
5.3.4 Dermatological Disorders
5.3.5 Respiratory Diseases
5.3.6 Other Indications
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 PDE5
6.2.2 PDE4
6.2.3 Viagra
6.2.4 Cialis
6.2.5 Levitra
6.2.6 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Genitourinary
6.3.2 Cardiovascular Diseases
6.3.3 Neurological Diseases
6.3.4 Dermatological Disorders
6.3.5 Respiratory Diseases
6.3.6 Other Indications
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 PDE5
7.2.2 PDE4
7.2.3 Viagra
7.2.4 Cialis
7.2.5 Levitra
7.2.6 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Genitourinary
7.3.2 Cardiovascular Diseases
7.3.3 Neurological Diseases
7.3.4 Dermatological Disorders
7.3.5 Respiratory Diseases
7.3.6 Other Indications
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 PDE5
8.2.2 PDE4
8.2.3 Viagra
8.2.4 Cialis
8.2.5 Levitra
8.2.6 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Genitourinary
8.3.2 Cardiovascular Diseases
8.3.3 Neurological Diseases
8.3.4 Dermatological Disorders
8.3.5 Respiratory Diseases
8.3.6 Other Indications
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 PDE5
9.2.2 PDE4
9.2.3 Viagra
9.2.4 Cialis
9.2.5 Levitra
9.2.6 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Genitourinary
9.3.2 Cardiovascular Diseases
9.3.3 Neurological Diseases
9.3.4 Dermatological Disorders
9.3.5 Respiratory Diseases
9.3.6 Other Indications
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Hanmi Science Holding
10.1.2 Boehringer Ingelheim
10.1.3 Takeda Pharmaceuticals
10.1.4 Pfizer
10.1.5 Omeros
10.1.6 Anacor Pharmaceuticals
10.1.7 Otsuka
10.1.8 Chiesi Farmaceutici
10.1.9 Verona Pharma
10.1.10 NuSirt Biopharma
10.2 PDE Inhibitors Sales Date of Major Players (2017-2020e)
10.2.1 Hanmi Science Holding
10.2.2 Boehringer Ingelheim
10.2.3 Takeda Pharmaceuticals
10.2.4 Pfizer
10.2.5 Omeros
10.2.6 Anacor Pharmaceuticals
10.2.7 Otsuka
10.2.8 Chiesi Farmaceutici
10.2.9 Verona Pharma
10.2.10 NuSirt Biopharma
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
Table PDE Inhibitors Product Type Overview
Table PDE Inhibitors Product Type Market Share List
Table PDE Inhibitors Product Type of Major Players
Table Brief Introduction of Hanmi Science Holding
Table Brief Introduction of Boehringer Ingelheim
Table Brief Introduction of Takeda Pharmaceuticals
Table Brief Introduction of Pfizer
Table Brief Introduction of Omeros
Table Brief Introduction of Anacor Pharmaceuticals
Table Brief Introduction of Otsuka
Table Brief Introduction of Chiesi Farmaceutici
Table Brief Introduction of Verona Pharma
Table Brief Introduction of NuSirt Biopharma
Table Products & Services of Hanmi Science Holding
Table Products & Services of Boehringer Ingelheim
Table Products & Services of Takeda Pharmaceuticals
Table Products & Services of Pfizer
Table Products & Services of Omeros
Table Products & Services of Anacor Pharmaceuticals
Table Products & Services of Otsuka
Table Products & Services of Chiesi Farmaceutici
Table Products & Services of Verona Pharma
Table Products & Services of NuSirt Biopharma
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global PDE Inhibitors Market Forecast (Million USD) by Region 2021f-2026f
Table Global PDE Inhibitors Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global PDE Inhibitors Market Forecast (Million USD) by Demand 2021f-2026f
Table Global PDE Inhibitors Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global PDE Inhibitors Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global PDE Inhibitors Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global PDE Inhibitors Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global PDE Inhibitors Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global PDE Inhibitors Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global PDE Inhibitors Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global PDE Inhibitors Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PDE5 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PDE4 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Viagra Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cialis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Levitra Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Genitourinary Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cardiovascular Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Neurological Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Dermatological Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Respiratory Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Other Indications Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PDE5 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PDE4 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Viagra Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cialis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Levitra Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Genitourinary Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cardiovascular Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Neurological Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Dermatological Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Respiratory Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Other Indications Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PDE5 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PDE4 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Viagra Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cialis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Levitra Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Genitourinary Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cardiovascular Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Neurological Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Dermatological Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Respiratory Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Other Indications Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PDE5 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PDE4 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Viagra Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cialis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Levitra Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Genitourinary Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cardiovascular Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Neurological Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Dermatological Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Respiratory Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Other Indications Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PDE5 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PDE4 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Viagra Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cialis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Levitra Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Genitourinary Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cardiovascular Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Neurological Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Dermatological Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Respiratory Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Other Indications Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PDE5 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PDE4 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Viagra Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cialis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Levitra Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Genitourinary Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cardiovascular Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Neurological Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Dermatological Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Respiratory Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Other Indications Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PDE Inhibitors Sales Revenue (Million USD) of Hanmi Science Holding 2017-2020e
Figure PDE Inhibitors Sales Revenue (Million USD) of Boehringer Ingelheim 2017-2020e
Figure PDE Inhibitors Sales Revenue (Million USD) of Takeda Pharmaceuticals 2017-2020e
Figure PDE Inhibitors Sales Revenue (Million USD) of Pfizer 2017-2020e
Figure PDE Inhibitors Sales Revenue (Million USD) of Omeros 2017-2020e
Figure PDE Inhibitors Sales Revenue (Million USD) of Anacor Pharmaceuticals 2017-2020e
Figure PDE Inhibitors Sales Revenue (Million USD) of Otsuka 2017-2020e
Figure PDE Inhibitors Sales Revenue (Million USD) of Chiesi Farmaceutici 2017-2020e
Figure PDE Inhibitors Sales Revenue (Million USD) of Verona Pharma 2017-2020e
Figure PDE Inhibitors Sales Revenue (Million USD) of NuSirt Biopharma 2017-2020e